ArticleJournal of neuro-oncology2018
Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.
Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 19 citations in OpenAlex.
- Single-Fraction Stereotactic Radiosurgery for Benign Perioptic Meningiomas: A Strategy for Long-Term Tumor Control and Radiation-Induced Optic Neuropathy Avoidance With a 10-Year Follow-up.Journal of Korean medical science · 2026Article
- Optimizing outcome in radiosurgery for spheno-orbital meningioma: the critical role of planning quality. Illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas.Neurosurgery · 2025Article
- Stereotactic radiotherapy of radiation-induced meningioma previously irradiated retrobulbar for Graves' ophthalmopathy: A case report.Radiology case reports · 2024Article
- Outcomes following CyberKnife robotic radiosurgery for pituitary adenomas-a large single-centre study.Ecancermedicalscience · 2024Article
- Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas.Journal of neuro-oncology · 2020Article
- Dosimetric accuracy of delivering SBRT using dynamic arcs on Cyberknife.Medical physics · 2020Article
- Postoperative Long-term Outcomes of Patient with Craniopharyngioma Based on CyberKnife Treatment.Cureus · 2020Article
- Treatment planning optimization with beam motion modeling for dynamic arc delivery of SBRT using Cyberknife with multileaf collimation.Medical physics · 2019Article
- Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas.Endocrine · 2019Article
- Radiosurgical techniques for the treatment of brain neoplasms: A short review.World journal of methodology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStereotactic radiation technique is widely reported as an effective treatment for various types of benign intracranial tumors. However, single fraction radiosurgery (SRS) is not recommended for tumors located close to the optic apparatus due to the restricted radiation tolerance dose of the optic pathway. Recent advances in radiotherapy include advanced frameless radiosurgery using hypofractionated stereotactic radiotherapy (HSRT), and this has become an attractive treatment option for perioptic tumors within 2-3 mm of the optic pathway. Accordingly, the aim of this study was to investigate the clinical outcomes of perioptic tumors treated with HSRT using CyberKnife® (CK) robotic radiosurgery system relative to tumor control, vision preservation and toxicity.
methodsThis retrospective analysis of prospectively collected data included consecutive 100 patients that were diagnosed with and treated for perioptic tumor at the Radiosurgery center, Ramathibodi Hospital during the January 2009 to December 2012 study period.
resultsThe median tumor volume was 6.81 cm
conclusionsAlthough a longer follow-up is needed, HSRT yields a high level of local control and vision preservation, and should be considered a treatment of choice for perioptic tumor located close to the optic apparatus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.